OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neuropsychiatric Effects of Antimicrobial Agents
Nicholas Zareifopoulos, George Panayiotakopoulos
Clinical Drug Investigation (2017) Vol. 37, Iss. 5, pp. 423-437
Closed Access | Times Cited: 54

Showing 1-25 of 54 citing articles:

Antibiotics and mental health: The good, the bad and the ugly
Katherine Dinan, Timothy G. Dinan
Journal of Internal Medicine (2022) Vol. 292, Iss. 6, pp. 858-869
Open Access | Times Cited: 45

Safety and Tolerability of Antimicrobial Agents in the Older Patient
Luca Soraci, Antonio Cherubini, Luca Paoletti, et al.
Drugs & Aging (2023) Vol. 40, Iss. 6, pp. 499-526
Open Access | Times Cited: 39

Antibiotics and the nervous system: More than just the microbes?
Kevin Champagne-Jorgensen, Wolfgang Kunze, Paul Forsythe, et al.
Brain Behavior and Immunity (2018) Vol. 77, pp. 7-15
Closed Access | Times Cited: 77

Prevalence, Contribution to Disease Burden and Management of Comorbid Depression and Anxiety in Chronic Obstructive Pulmonary Disease: A Narrative Review
Nicholas Zareifopoulos, Aggeliki Bellou, Agathi Spiropoulou, et al.
COPD Journal of Chronic Obstructive Pulmonary Disease (2019) Vol. 16, Iss. 5-6, pp. 406-417
Open Access | Times Cited: 68

Prevalence of Comorbid Chronic Obstructive Pulmonary Disease in Individuals Suffering from Schizophrenia and Bipolar Disorder: A Systematic Review
Nicholas Zareifopoulos, Aggeliki Bellou, Agathi Spiropoulou, et al.
COPD Journal of Chronic Obstructive Pulmonary Disease (2018) Vol. 15, Iss. 6, pp. 612-620
Closed Access | Times Cited: 48

Antibiotics and the Nervous System—Which Face of Antibiotic Therapy Is Real, Dr. Jekyll (Neurotoxicity) or Mr. Hyde (Neuroprotection)?
Magdalena Hurkacz, Łukasz Dobrek, Anna Wiela−Hojeńska
Molecules (2021) Vol. 26, Iss. 24, pp. 7456-7456
Open Access | Times Cited: 36

Depressive and Other Adverse CNS Effects of Fluoroquinolones
Piotr Wierzbiński, Joanna Hubska, Michał Henzler, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 8, pp. 1105-1105
Open Access | Times Cited: 14

Comparative Analysis of Adverse Drug Reactions Associated with Fluoroquinolones and Other Antibiotics: A Retrospective Pharmacovigilance Study
Hanan Alshareef, Khalidah A. Alenzi, Budor Albalawi, et al.
Drug Healthcare and Patient Safety (2025) Vol. Volume 17, pp. 51-62
Open Access

Drug-induced hyperacusis: a disproportionality analysis of the FAERS database
Huimin Lin, Qianqian Wang, Haiting Liu, et al.
Expert Opinion on Drug Safety (2025), pp. 1-9
Closed Access

Discontinuation of dolutegravir, elvitegravir/cobicistat and raltegravir because of toxicity in a prospective cohort
Josep M. Llibre, Alexandra Montoliu, JM Miró, et al.
HIV Medicine (2019) Vol. 20, Iss. 3, pp. 237-247
Open Access | Times Cited: 37

Assessing the association between fluoroquinolones and emerging adverse drug reactions raised by regulatory agencies: An umbrella review
Milo Gatti, Matteo Bianchin, Emanuel Raschi, et al.
European Journal of Internal Medicine (2020) Vol. 75, pp. 60-70
Closed Access | Times Cited: 36

Psychosis as an adverse effect of antibiotics
Norah Essali, Brian J. Miller
Brain Behavior & Immunity - Health (2020) Vol. 9, pp. 100148-100148
Open Access | Times Cited: 32

Nontuberculous Mycobacteria
Cara D. Varley, Kevin Winthrop
Clinics in Chest Medicine (2022) Vol. 43, Iss. 1, pp. 89-98
Closed Access | Times Cited: 21

Clinically Relevant Interactions between Atypical Antipsychotics and Anti-Infective Agents
Edoardo Spina, María Antonietta Barbieri, Giuseppe Cicala, et al.
Pharmaceuticals (2020) Vol. 13, Iss. 12, pp. 439-439
Open Access | Times Cited: 29

Redesigning the kinetics of lysozyme amyloid aggregation by cephalosporin molecules
Shivani A. Muthu, Afnaan Qureshi, Rahul Sharma, et al.
Journal of Biomolecular Structure and Dynamics (2024), pp. 1-16
Closed Access | Times Cited: 3

Psychiatric disorders associated with fluoroquinolones: a pharmacovigilance analysis of the FDA adverse event reporting system database
Wen-Long Xie, Meng-lan Ge, Dan Chen, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 3

Neuro-Psychiatric Alterations in Patients with Diabetic Foot Syndrome
Emmanuel Navarro‐Flores, Pilar Pérez‐Ros, Francisco Miguel Martínez‐Arnau, et al.
CNS & Neurological Disorders - Drug Targets (2019) Vol. 18, Iss. 8, pp. 598-608
Closed Access | Times Cited: 23

Infections, antibiotic treatment and the Microbiome in relation to schizophrenia
Amalie Wandel Klein-Petersen, Ole Köhler‐Forsberg, Michael E. Benros
Schizophrenia Research (2019) Vol. 234, pp. 71-77
Closed Access | Times Cited: 22

Repurposing antitubercular agent isoniazid for treatment of prostate cancer
Qingzhi Lv, Dun Wang, Zimeng Yang, et al.
Biomaterials Science (2018) Vol. 7, Iss. 1, pp. 296-306
Closed Access | Times Cited: 20

Macrolide-associated ototoxicity: a cross-sectional and longitudinal study to assess the association of macrolide use with tinnitus and hearing loss
Anna Vanoverschelde, Berthe C. Oosterloo, Nelly F Ly, et al.
Journal of Antimicrobial Chemotherapy (2021) Vol. 76, Iss. 10, pp. 2708-2716
Open Access | Times Cited: 14

A VigiBase Descriptive Study of Fluoroquinolone-Associated Peripheral Nervous System Disorders
Madalina Huruba, Andreea Farcaș, Daniel-Corneliu Leucuța, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 2, pp. 143-143
Open Access | Times Cited: 8

Antibiotic exposure is associated with decreased risk of psychiatric disorders
Ilan A. Kerman, Matthew E. Glover, Yezhe Lin, et al.
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 1

Antibiotic-induced neuropsychiatric toxicity: epidemiology, mechanisms and management strategies –a narrative literature review
Ali Althubyani, Samantha Canto, Huy P. Pham, et al.
Drugs in Context (2024) Vol. 13, pp. 1-18
Open Access | Times Cited: 1

Delirium associated with the use of macrolide antibiotics: a review
Ana V. Pejčić
International Journal of Psychiatry in Clinical Practice (2020) Vol. 26, Iss. 1, pp. 29-42
Closed Access | Times Cited: 10

Page 1 - Next Page

Scroll to top